MedTrace Logo

Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2

NCT02340299 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-08-05

Study results available
· View outcomes & findings →

Summary

To investigate whether nasal high frequency oscillation ventilation (nHFOV) immediately after extubation reduces the arterial partial pressure of carbon dioxide (paCO2) at 72 hours after extubation in comparison with nasal continuous positive airway pressure (nCPAP) in very low birth weight infants (VLBWs).

Conditions

  • Respiratory Distress Syndrome, Newborn
  • Respiratory Tract Diseases

Interventions

DEVICE

nHFOV

Extubation to ventilator-derived nHFOV using binasal prongs

DEVICE

nCPAP

Extubation to ventilator-derived nCPAP using binasal prongs

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Christoph Czernik, MD PhD · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02340299 on ClinicalTrials.gov